Rafeh Naqash: 1st steps among many upcoming initiatives for the Naqash lab
Rafeh Naqash shared a post by Hassan Abushukair, Associate Researcher at OU Health Stephenson Cancer Center, on X, adding:
”Super excited to have Hassan Abushukair join us to help propel some of our clinical and translational work around immunology genomics in collaboration with OU Oncology Science. 1st steps among many upcoming initiatives for the Naqash lab.”
Quoting Hassan Abushukair’s post:
”I am excited to start a new chapter in my journey as an associate researcher at OU Health Stephenson Cancer Center’s Oncology Science department with Rafeh Naqash and Tae Gyu Oh! I am also fortunate to be doing a master’s degree in clinical and translational sciences at University of Oklahoma.
A huge milestone for me that I couldn’t have reached without the help and support of my family and mentors. Thank you to everyone who believed in me and propelled me to levels I only dreamed of, especially Rafeh Naqash for all the guidance and opportunities.
We will continue our immuno-oncology work using innovative omics technologies to gain enhanced granular understanding of efficacy/toxicity in hopes of changing patients lives to the better.”
Source: Rafeh Naqash/X and Hassan Abushukair/X
Rafeh Naqash is an Assistant Professor in the early phase division of the Stephenson Cancer Center at the University of Oklahoma. Dr. Naqash focuses on conducting innovative clinical trials and biomarker-based research. Dr. Naqash has published in high-impact journals and has collaborated widely with researchers worldwide.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023